Dovato 50-300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FT334
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,064
Award facts
- Contract value 100% obligated
- $26,063.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DOVATO 50-300 mg tablets (30-count packages) valued at $26,063.85 under a firm fixed price contract type. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally. DOVATO, an antiretroviral medication used in HIV treatment, falls within the company's extensive portfolio of specialty medications, brand-name and generic drugs, and medical supplies delivered to customers including the Defense Health Agency and U.S. Coast Guard. The delivery order structure and firm fixed pricing demonstrate AmerisourceBergen Drug Corp's established capability to meet federal pharmaceutical procurement requirements efficiently within the DLA's strategic medical supply framework.
Quick answers
Who was awarded contract SPE2DR26FT334?
SPE2DR26FT334 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FT334 worth?
The government has obligated $26,064 on SPE2DR26FT334.
Is contract SPE2DR26FT334 an order under another contract?
Yes. SPE2DR26FT334 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT334 competed?
The extent of competition for SPE2DR26FT334 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award